Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Galaxy Digital Inc. Class A Common Stock (GLXY) vs ResMed Inc. (RMD) Price & Performance

Galaxy Digital Inc. Class A Common StockTrade
ResMed Inc.Trade

Price performance (Past 24H)

Key statistics

Galaxy Digital Inc. Class A Common Stock vs ResMed Inc. — how do they compare? Galaxy Digital Inc. Class A Common Stock trades at $20.37 (market cap $3.90B), while ResMed Inc. trades at $230.12 (market cap $31.89B). The key difference: ResMed Inc. is far larger — about 8.2× Galaxy Digital Inc. Class A Common Stock's market cap, and ResMed Inc. pays a 1.16% dividend while Galaxy Digital Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Galaxy Digital Inc. Class A Common Stock for 1 Days and ResMed Inc. for 51 Days on average.

GLXYRMD
Market Cap
$3.90B$31.89B
Volume
7,887,173618,314
Sector
FinancialsHealth
52-Week High
$42.86$277.88
52-Week Low
$16.84$182.82
Typical Hold Time
1 Days51 Days
Enterprise Value
$6.36B$31.24B
Dividend Yield
—1.16%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Galaxy Digital Inc. Class A Common Stock

No Aura AI signal available yet.

ResMed Inc.

ResMed (RMD) trades at $230.91, up 2.18% today, with a bullish technical signal and strong fundamentals. The company reported consistent earnings beats in recent quarters, with Q3 2026 EPS expected at $2.68. Revenue grew to $5.15B in 2025, with a net income margin of 26.94%. Analyst consensus is a buy, with a $242.70 price target. Recent news highlights EPS growth targets of 12%-14% and participation in investor conferences.

Outlook is positive due to robust earnings growth and market share gains, but risks include competitive pressures and regulatory investigations. The stock offers upside to the consensus target, supported by institutional buying and solid cash flow generation.

Returns comparison

Trailing returns across standard periods

About Galaxy Digital Inc. Class A Common Stock

Galaxy provides digital-asset financial services and data center infrastructure. Its digital-assets business includes trading, asset management, investment banking, staking, tokenization, and custody technology.

Read more on GLXY →

About ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Read more on RMD →